Operations and Regulatory Consulting, Quality, Compliance, GMP, Regulatory

Remote Regulatory Assessments – Q&A: Here to Stay

February 9, 2024 || Emily Purchase
 
On January 26, 2024, the Food and Drug Administration (FDA) provided notification of a revised draft guidance on Remote Regulatory Assessments (RRAs).  The FDA has updated its guidance on remote regulatory assessments (RRAs), emphasizing that they differ from inspections and outlining new powers granted by a recent spending bill. The…

EU & US MRA Fully Operational – What You Need to Know!

July 25, 2019 ||
 
Background In 1998, the EU and the US signed a broad Mutual Recognition Agreement (MRA), which included a Pharmaceutical Annex providing for anticipated and limited reliance on each other’s Good Manufacturing Practice (GMP) inspections. However, this Agreement was never fully implemented.